Report on faulty hip replacement implants ready, will be filed in a week: Centre to SC

Image
Press Trust of India New Delhi
Last Updated : Dec 03 2018 | 7:15 PM IST

The Centre informed the Supreme Court Monday that the report of its panel on alleged "faulty" hip implants, made by the US-based pharma major Johnson and Johnson, is ready and will be filed within a week.

The apex court on October 5 had asked the Centre to file its response to the PIL alleging that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients.

It had also asked the Union Ministry of Health and Family Welfare to apprise it within two months about the actions, if any, taken after an expert committee had allegedly found the pharma firms guilty of "medical negligence".

A bench comprising Chief Justice Ranajn Gogoi and Justices S K Kaul and K M Joseph has now asked the Centre to file its response within a week.

"Counsel appearing for the Union of India states that the report of the Committee headed by Dr Arun Agarwal, Professor of ENT, Maulana Azad Medical College, is ready and will be filed within a week. List the matter after the report is received by the Registry. Let a copy of the said report be given to each of the contesting parties," the bench said in its order.

Earlier, senior lawyer Salman Khurshid and advocate Vivek Narayan Sharma had referred to the fact that the central government had in 2017 set up a committee headed by Agarwal to look into the aftermath of the disaster caused by the faulty hip implant produced and distributed by the US firm, its Indian subsidiary and DePuy Orthopaedics INC collectively.

"The Committee has found Johnson and Johnson guilty of medical negligence, however, till date nothing has been done to discover vast number of patients who had undergone hip transplant," said the plea filed by one Arun Kumar Goenka, whose mother had died following faulty hip implant surgeries.

The court, taking note of the PIL, had sought the assistance of one of the Additional Solicitor Generals and had listed the matter after two months.

The plea has sought a direction to the Centre and Central Drugs Standard Control Organisation for taking effective measures to save lives of those who have undergone "DePuy ASR hip implant surgeries and would be unknowingly living a life in hell, if alive or may be dead, due to the negligent acts of respondents."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 03 2018 | 7:15 PM IST

Next Story